Doudna-Backed Azalea Therapeutics Demonstrates Tumor Clearance With Single-Dose In Vivo CAR-T in Nature Study
A two-vector system inserts a CAR transgene at the TRAC locus inside the body, generating functional cancer-killing T cells without ex vivo manufacturing or lymphodepletion.
4 min read3 sources